These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3033190)

  • 21. Itraconazole in pityriasis versicolor: ultrastructural changes in Malassezia furfur produced during treatment.
    Galimberti RL; Villalba I; Galarza S; Raimondi A; Flores V
    Rev Infect Dis; 1987; 9 Suppl 1():S134-8. PubMed ID: 3027839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of the susceptibility of Candida strains to ketoconazole and itraconazole in in vitro experiments].
    Gwieździński Z; Nierebińska E; Urbanowski S
    Przegl Dermatol; 1989; 76(5-6):399-404. PubMed ID: 2561924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of ketoconazole in combination with other inhibitors of sterol synthesis on fungal growth.
    Sud IJ; Feingold DS
    Antimicrob Agents Chemother; 1985 Oct; 28(4):532-4. PubMed ID: 4073876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations.
    Tucker RM; Denning DW; Hanson LH; Rinaldi MG; Graybill JR; Sharkey PK; Pappagianis D; Stevens DA
    Clin Infect Dis; 1992 Jan; 14(1):165-74. PubMed ID: 1315160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An azole-resistant isolate of Malassezia pachydermatis.
    Nijima M; Kano R; Nagata M; Hasegawa A; Kamata H
    Vet Microbiol; 2011 Apr; 149(1-2):288-90. PubMed ID: 21074337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of anti-seborrhea substances against Pityrosporum ovale in vitro].
    Nenoff P; Haustein UF
    Hautarzt; 1994 Jul; 45(7):464-7. PubMed ID: 7928340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes.
    Back DJ; Tjia JF
    Br J Clin Pharmacol; 1991 Nov; 32(5):624-6. PubMed ID: 1659439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction potential of antifungals containing an imidazole or triazole moiety. Miconazole and ketoconazole, but not itraconazole are able to induce hepatic drug metabolizing enzymes of male rats at high doses.
    Lavrijsen K; Van Houdt J; Thijs D; Meuldermans W; Heykants J
    Biochem Pharmacol; 1986 Jun; 35(11):1867-78. PubMed ID: 3013201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Azoles, allylamines and drug metabolism.
    Back DJ; Tjia JF; Abel SM
    Br J Dermatol; 1992 Feb; 126 Suppl 39():14-8. PubMed ID: 1311943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluconazole, itraconazole and ketoconazole in-vitro activity. A comparative study.
    Arzeni D; Barchiesi F; Ancarani F; Scalise G
    J Chemother; 1991 Jun; 3(3):139-42. PubMed ID: 1655990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro antifungal efficacy of ciclopirox olamine alone and associated with zinc pyrithione compared to ketoconazole against Malassezia globosa and Malassezia restricta reference strains.
    Roques C; Brousse S; Panizzutti C
    Mycopathologia; 2006 Dec; 162(6):395-400. PubMed ID: 17146583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative sensitivity of yeasts to ketoconazole, itraconazole and fluconazole using a liquid medium standardized micromethod].
    Guinet R; Marlier H
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):575-8. PubMed ID: 2166937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time-kill assay of itraconazole against Malassezia species.
    Sugita T; Tsubuku H; Tajima M; Tsuboi R; Nishikawa A
    Microbiol Immunol; 2006; 50(8):625-7. PubMed ID: 16924147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ketoconazole inhibits Malassezia furfur morphogenesis in vitro under filamentation optimized conditions.
    Youngchim S; Nosanchuk JD; Chongkae S; Vanittanokom N
    Arch Dermatol Res; 2017 Jan; 309(1):47-53. PubMed ID: 27885419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mode of action of itraconazole: morphological aspects.
    Borgers M; Van de Ven MA
    Mycoses; 1989; 32 Suppl 1():53-9. PubMed ID: 2561185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The activity of ketoconazole and other azoles against Trypanosoma cruzi: biochemistry and chemotherapeutic action in vitro.
    Goad LJ; Berens RL; Marr JJ; Beach DH; Holz GG
    Mol Biochem Parasitol; 1989 Jan; 32(2-3):179-89. PubMed ID: 2494453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of R126638 and ketoconazole against Malassezia species.
    Faergemann J; Ausma J; Borgers M
    Acta Derm Venereol; 2006; 86(4):312-5. PubMed ID: 16874415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced phagocytosis and intracellular killing of Pityrosporum ovale by human neutrophils after exposure to ketoconazole is correlated to changes of the yeast cell surface.
    Richardson MD; Shankland GS
    Mycoses; 1991; 34(1-2):29-33. PubMed ID: 1833641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Itraconazole: pharmacologic studies in animals and humans.
    Van Cauteren H; Heykants J; De Coster R; Cauwenbergh G
    Rev Infect Dis; 1987; 9 Suppl 1():S43-6. PubMed ID: 3027845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The activity of ketoconazole and itraconazole against Aspergillus fumigatus in mixed cultures with macrophages or leukocytes.
    Aerts F; Van Cutsem J; De Brabander M
    Mykosen; 1986 Apr; 29(4):165-76. PubMed ID: 3012331
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.